Health and Human Services (HHS)

Importation isn't a silver bullet to lower drug prices

Illustration of pills and abstract dollar.
Illustration: Sarah Grillo/Axios

The Trump administration is moving forward on the traditionally Democratic policy of importing prescription drugs from abroad, but the impact — if the proposals are actually finalized — could be pretty muted.

The big picture: While importation could help some patients afford their drugs, the policy overall is an attempt to take advantage of other countries' lower drug prices while avoiding taking direct action to limit prices in the U.S.

The Indian Health Service is still in turmoil

A hand holding up a broken health care symbol x-ray
Illustration: Sarah Grillo/Axios

The Indian Health Service remains deeply troubled, according to two new reports released yesterday from the Department of Health and Human Services' Office of the Inspector General.

Why it matters: The IHS is responsible for more than 2 million Native Americans — a population that tends to need a lot of care, much of it specialized. Yet the IHS has been beset for years by underfunding and mismanagement.